Is this you? Create Your Porfile
Avatar

Alan Naylor

University of California, Berkeley

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Alan Naylor is active.

Explore More

Publication

Featured researches published by Alan Naylor.

Archive | 1994

3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins

Duncan Robert Armour; Brian L. Evans; Gerard Martin Paul Giblin; Michael Menteith Hann; Tania Hubbard; Xiao-Qing Lewell; David Middlemiss; Alan Naylor; Neil Anthony Pegg; Maria Victoria Vinader; Stephen Paul Watson

Archive | 1994

Benzofuran derivatives as tachykinin antagonists

Alan Naylor; Brian L. Evans

Archive | 2003

Pyridine derivatives as cb2 receptor modulators

Andrew John Eatherton; Gerard Martin Paul Giblin; Richard Howard Green; Jennifer Margaret Doughty; Karamjit Singh Jandu; William Leonard Mitchell; Alan Naylor; Giovanni Palombi; Derek Anthony Rawlings; Brian Peter Slingsby; Andrew Richard Whittington

Archive | 2000

Formulations of adenosine a1 agonists

Charanjit Glaxo Wellcome plc Bountra; Nicholas Maughan Clayton; Alan Naylor

Archive | 2006

Pyrazole compounds as prostaglandin receptors ligands

Elizabeth Ann GlaxoSmithKline Conway; Gerard Martin Paul Giblin; Mairi GlaxoSmithKline Gibson; Adrian Hall; Thomas George Christopher Hayhow; Mark Patrick Healy; David Nigel GlaxoSmithKline Hurst; Ian Reginald GlaxoSmithKline Kilford; Stephen Carl GlaxoSmithKline Mckeown; Alan Naylor; Helen Susanne Price; Derek Anthony Rawlings

Archive | 2003

Pyrimidine derivatives and their use as CB2 modulators

Andrew John Eatherton; Gerard Martin Paul Giblin; Richard Howard Green; William Leonard Mitchell; Alan Naylor; Derek Anthony Rawlings; Brian Peter Slingsby; Andrew Richard Whittington

Archive | 2002

Pyrimidine derivatives useful as selective COX-2 inhibitors

Alan Naylor; Jeremy John Payne; Neil Anthony Pegg

Archive | 2006

Imidazopyridine Derivatives as Cannabinoid Receptor Ligands

Andrew John Eatherton; Gerard Martin Paul Giblin; William Leonard Mitchell; Alan Naylor; Lee William Page; Martin Swarbrick; Jennifer Anne Sweeting

Archive | 2005

Pyridine Derivatives and Their Use as Cb2 Receptor Modulators

Andrew John Eatherton; Gerard Martin Paul Giblin; William Leonard Mitchell; Alan Naylor

Archive | 2005

2- (phenylamino) -pyrimidin-5-amides as cannabinoid 2 receptors modulators for the treatment of immune or inflammatory disorders

Andrew John Eatherton; Gerard Martin Paul Giblin; William Leonard Mitchell; Alan Naylor; Derek Anthony Rawlings; Ian David Glaxosmithkline Wall

Explore More

Collaboration

Dive into the Alan Naylor's collaboration.

Top Co-Authors
Avatar

Gerard Martin Paul Giblin

University of California

View shared research outputs
Top Co-Authors
Avatar

Andrew John Eatherton

University of California

View shared research outputs
Top Co-Authors
Avatar

William Leonard Mitchell

University of California

View shared research outputs
Top Co-Authors
Avatar

Derek Anthony Rawlings

University of California

View shared research outputs
Top Co-Authors
Avatar

Brian L. Evans

University of Texas at Austin

View shared research outputs
Top Co-Authors
Avatar

Brian Peter Slingsby

University of California

View shared research outputs
Top Co-Authors
Avatar

Charanjit Bountra

University of California

View shared research outputs
Top Co-Authors
Avatar

Andrew Richard Whittington

University of California

View shared research outputs
Top Co-Authors
Avatar

Elizabeth Ann GlaxoSmithKline Conway

University of California

View shared research outputs
Top Co-Authors
Avatar

Ian Baxter GlaxoSmithKline Campbell

University of California

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge